A plain-English look at how Intuitive Surgical's da Vinci robots have translated into $10.1B in revenue and a $149.5B market value.
Walk into an operating room today and there's a decent chance a machine with slender robotic arms is standing beside the surgeon, translating hand movements into tiny, precise incisions. That machine is almost certainly a da Vinci system, built by Intuitive Surgical, the Sunnyvale, California company that has spent three decades turning robotic-assisted surgery from a novelty into a fixture of modern hospitals.
From Startup to Surgical Staple
Founded in 1995 and public since its June 2000 IPO, Intuitive Surgical didn't just build a robot — it built an entire ecosystem around it. The company designs the da Vinci systems themselves, but it also sells the specialized instruments, disposable accessories, and warranty services that hospitals need to keep the machines running day after day.
A Global Footprint
That ecosystem has scaled remarkably. Intuitive has placed more than 10,000 da Vinci systems in hospitals worldwide, with over 6,000 of those installed in the United States alone. The company also describes a growing presence in emerging markets, suggesting its reach extends well beyond its home base.
What the Revenue Numbers Show
In fiscal year 2025, Intuitive Surgical generated $10.1 billion in revenue — a figure that places it firmly among the larger players in medical devices. More telling is the trajectory: revenue grew 76% from FY2021 to FY2025, a pace that reflects steady adoption of robotic surgery rather than a single blockbuster year.
Profit, Not Just Growth
Growth alone doesn't guarantee financial health, but Intuitive's underlying economics look strong. The company posted net income of $2.9 billion in FY2025, meaning it kept a substantial share of every revenue dollar as profit. That translates into a net margin of 28.6% — roughly 29 cents of profit for every dollar of sales — alongside a gross margin of 66.0%, which shows the company retains most of its revenue after accounting for the direct costs of building its systems and instruments.
Balance Sheet and Market Value
Intuitive's total assets stand at $20.5 billion, giving a sense of the resources — cash, equipment, and other holdings — backing its operations. On the public markets, the company carries a market capitalization of $149.5 billion, a figure that reflects how investors collectively value the entire business today.
Reading the Share Price
Shares recently traded at $415.10, delayed by fifteen minutes from live markets, and are currently 30% below the company's 52-week high. The stock's price-to-earnings ratio sits at 52.7, meaning the market capitalization is a multiple of 52.7 times the company's annual profit — a figure that simply describes how the stock is priced relative to earnings, without implying anything about future performance.
Scale of the Organization
Behind these numbers is a workforce of approximately 17,021 employees, engineers, technicians, and support staff who design, manufacture, and service the da Vinci systems installed across thousands of hospitals. It's a relatively lean headcount for a company generating this much revenue, hinting at how much of the business runs on recurring instrument and service sales rather than one-off equipment purchases alone.
The Bottom Line
Intuitive Surgical, listed on NASDAQ under the ticker ISRG, has built a business that pairs meaningful revenue growth with healthy profit margins and a substantial market valuation. This article is factual reporting drawn from public filings and market data, not investment advice.
